Appeal Waivers Narrow “Eligible Defendant” Status Under Post-Conviction Rule 2 to Claims of an “Illegal” Sentence

I. Introduction

Ortiz v. State of Indiana (Ind. May 19, 2026) addresses when a convicted defendant may pursue a belated appeal under Indiana Post-Conviction Rule 2 (“PCR 2”) after having signed a plea agreement containing a sentencing-appeal waiver. Carlos T. Ortiz pleaded guilty to murder and expressly waived “his right to challenge the sentence on the basis that it is erroneous.” Years later, he sought a PCR 2 belated appeal arguing the trial court relied on an improper aggravator (the “shaken baby syndrome” aggravator) when enhancing his sentence.

The key legal issue was not whether Ortiz’s sentencing argument was correct, but whether—given the appeal waiver—he was an “eligible defendant” entitled even to seek a belated direct appeal under PCR 2. The case also resolved an ongoing conflict in Court of Appeals decisions about whether “improper aggravators” render a sentence “illegal” in a way that can overcome an appeal waiver.

II. Summary of the Opinion

The Indiana Supreme Court affirmed the trial court’s disposition of Ortiz’s PCR 2 petition, holding that:

  • PCR 2 “eligible defendant” status requires that the petitioner would have had the right to bring the same direct appeal if timely filed.
  • Under Anderson v. State, a sentencing-appeal waiver can be overcome only by a claim that the sentence is “illegal,” meaning outside the statutory range or unconstitutional.
  • Ortiz’s claim—that the trial court relied on an improper aggravator—is an abuse-of-discretion-type sentencing claim, not a claim of “illegality” under Anderson’s narrow definition; therefore, the waiver bars it, and Ortiz is not “eligible” under PCR 2.

The Court remanded with instructions that the trial court’s disposition be entered as a dismissal without prejudice (rather than a denial), signaling that the procedural posture is non-merits and leaving open the possibility of a future, properly pleaded claim that could establish eligibility.

III. Analysis

A. Precedents Cited

1. Anderson v. State

Anderson v. State, 269 N.E.3d 817 (Ind. 2025), is the doctrinal centerpiece. Anderson reaffirmed “the validity of appeal-waiver provisions” and held that even broad waivers cannot foreclose challenges to an “illegal” sentence, defined narrowly as a sentence “outside the prescribed statutory range or ... unconstitutional.” Ortiz extends Anderson’s waiver analysis into the PCR 2 eligibility inquiry: if a claim could not overcome the waiver on timely direct appeal, it cannot make the defendant “eligible” for a belated appeal either.

2. Wihebrink v. State; Haddock v. State; Crider v. State

Wihebrink v. State, 181 N.E.3d 448 (Ind. Ct. App. 2022), trans. denied, held that reliance on invalid aggravators does not make a sentence “illegal” or “contrary to law,” distinguishing illegality from abuse of discretion. It relied on Crider v. State, 984 N.E.2d 618 (Ind. 2013), for the proposition that the sentencing court’s weighing and use of aggravators is generally a discretionary question.

Haddock v. State, 112 N.E.3d 763 (Ind. Ct. App. 2018), trans. denied, took a broader view, allowing belated appeals to proceed despite waivers in circumstances like Ortiz’s. The Court of Appeals majority below chose Haddock over Wihebrink, citing the lack of horizontal stare decisis.

The Supreme Court, building on Anderson, effectively settles the Haddock/Wihebrink divide for PCR 2 waiver cases: claims about “improper aggravators,” standing alone, do not constitute “illegal sentence” claims capable of defeating an appeal waiver.

3. Garza v. Idaho

The Court cited Garza v. Idaho, 586 U.S. 232 (2019), to emphasize both (a) plea bargains as contracts and (b) the principle that “no appeal waiver serves as a bar to all appellate claims.” Ortiz uses Garza to argue that some claims survive waivers; the Court agrees in principle but confines the surviving category (for these purposes) to Anderson’s “illegal sentence” definition.

4. Post-conviction and appellate-procedure cases: Moshenek v. State; Kelly v. State; Hill v. State; Gallagher v. State

  • Moshenek v. State, 868 N.E.2d 419 (Ind. 2007): establishes abuse-of-discretion review for trial court decisions on permission to file belated notices under PCR 2.
  • Kelly v. State, 257 N.E.3d 782 (Ind. 2025): recognizes direct appeal as the “primary route” for review and provides de novo review for “pure legal questions” like interpreting post-conviction rules.
  • Hill v. State, 960 N.E.2d 141 (Ind. 2012), and Gallagher v. State, 410 N.E.2d 1290 (Ind. 1980): both emphasize PCR 2’s traditional focus on diligence and lack of fault, and that merits generally “have no bearing” on restoring wrongfully denied appeal rights—an important backdrop for Justice Goff’s concerns about how far PCR 2 screening should go.

5. Threshold screening analogy and preservation doctrine: Bellwether Props., LLC v. Duke Energy Ind., Inc.; Plank v. Cmty. Hosps. of Ind., Inc.

The Court analogized the eligibility inquiry to a Trial Rule 12(B)(6) motion via Bellwether Props., LLC v. Duke Energy Ind., Inc., 87 N.E.3d 462 (Ind. 2017): the question is whether alleged facts, if proved, would entitle relief—here, relief meaning the ability to overcome an appeal waiver and thus qualify as “eligible.”

The Court also enforced issue preservation through Plank v. Cmty. Hosps. of Ind., Inc., 981 N.E.2d 49 (Ind. 2013), holding that Ortiz waived new constitutional arguments first raised at transfer.

6. Potential exception signaled: Crouse v. State

The Court, citing Judge Vaidik’s concurrence in Crouse v. State, 158 N.E.3d 388 (Ind. Ct. App. 2020), indicated that some aggravator-based arguments might plausibly allege “illegality” if the challenged aggravator is a necessary legal prerequisite for the sentence imposed (e.g., if consecutive sentences require at least one valid aggravator). The Court did not decide that question but left the door open in principle—while finding it inapplicable to Ortiz because other aggravators supported the enhancement and because Ortiz did not frame his claim that way.

7. Constitutional “illegality” illustration: United States v. Adkins

To show the high bar for “unconstitutional” illegality in this context, the Court quoted United States v. Adkins, 743 F.3d 176 (7th Cir. 2014), listing examples like sentencing based on race or a deprivation of minimum civilized procedure. Ortiz’s attack on a single statutory aggravator did not plausibly render the entire sentence unconstitutional where other aggravators independently supported it.

8. Justice Goff’s practical overlay: Kling v. State

Justice Goff’s concurrence referenced Kling v. State, 837 N.E.2d 502 (Ind. 2005), noting the State Public Defender need not pursue PCR 2 where the petition is not meritorious or in the interest of justice—supporting the view that the Court’s eligibility-screening approach may reduce inefficiency and diminish future filings inconsistent with Anderson.

B. Legal Reasoning

1. PCR 2 eligibility is tied to the “right” to bring a direct appeal

The Court grounded its holding in the text of PCR 2: an “eligible defendant” is one who “would have the right to challenge on direct appeal a conviction or sentence” if the appeal were timely. This “right” is not an abstract constitutional ideal; it is the operative, enforceable right after accounting for valid waivers in a plea agreement.

2. Appeal waivers contractually narrow the right to appeal; “illegal sentence” is the nonwaivable floor

Following Anderson (and Garza’s contract framing), the Court treated the waiver’s scope as determinative: broad waiver, narrow remaining “right.” The remaining, nonwaivable core is limited to “illegal sentence” claims as Anderson defines them. Therefore, a PCR 2 petitioner subject to a waiver must allege, at minimum, an Anderson-illegality theory to remain “eligible.”

3. Improper-aggravator claims are not “illegal sentence” claims under Anderson

Ortiz argued that sentencing based on improper aggravating factors is not permitted. The Court rejected this as a category mistake after Anderson and Indiana Code section 35-38-1-7.1(d): so long as the sentence is authorized by statute and constitutional, the presence/absence or correctness of aggravators does not determine “legality.” Those are discretionary issues reviewed for abuse of discretion, and thus fall within the waiver.

4. The Court’s “12(B)(6)-like” threshold: eligibility screening without deciding ultimate merits

The Court distinguished between (a) deciding whether Ortiz would ultimately win and (b) deciding whether his pleaded theory—assuming it were correct—could defeat the waiver. If not, then he lacks the “right” required for eligibility and his petition fails at the threshold. This reconciles PCR 2’s limited purpose with the practical necessity of not resurrecting appeals that are categorically barred by waiver.

5. Waiver and alternative aggravators defeat Ortiz’s late-blooming constitutional theory

Ortiz attempted at transfer to recast his argument as a due-process challenge to the shaken-baby-syndrome aggravator. The Court held it waived under Plank. Even on the merits framing, the Court reasoned that invalidating one aggravator would not make the overall sentence unconstitutional or outside the statutory range where other aggravators independently supported the enhanced term.

6. Disposition: dismissal without prejudice

By directing the trial court to enter dismissal without prejudice, the Court reinforced that the decision is a gatekeeping, eligibility-based ruling, not an adjudication on the merits of any properly presented illegality claim that might be raised in a future proceeding.

C. Impact

  • Unified rule for belated-appeal waiver cases: After Ortiz, defendants with sentencing-appeal waivers face the same substantive limitation in PCR 2 as on timely direct appeal: only Anderson-style “illegal sentence” claims can defeat the waiver and establish eligibility.
  • Resolution of a Court of Appeals split: In practical effect, Ortiz extends Anderson’s rejection of Haddock’s broader “illegality” view and reinforces Wihebrink’s approach in the belated-appeal context.
  • Procedural efficiency: Trial courts may screen PCR 2 petitions for waiver-overcoming allegations at the eligibility stage, potentially reducing futile belated appeals and conserving public defense resources—an explicit concern highlighted by Justice Goff.
  • Incentive effects on plea bargaining and litigation strategy: Defendants and counsel must treat sentencing-appeal waivers as meaningfully preclusive of “erroneous sentence” arguments and must preserve any constitutional or statutory-range claims early. Post hoc recharacterizations face waiver and skepticism.
  • Limited opening for aggravator-based “illegality” theories: The Court’s discussion of Crouse suggests a narrow corridor where an “invalid aggravator” argument could amount to illegality if the sentence imposed is legally unavailable without a valid aggravator (e.g., certain consecutive-sentence prerequisites). Future litigants will likely test that boundary.

IV. Complex Concepts Simplified

  • Belated appeal (PCR 2): A special procedure allowing a late notice of appeal if the defendant was not at fault and acted diligently—but only if the defendant is “eligible” (i.e., would have had the right to appeal if timely).
  • Appeal waiver: A plea-agreement term where the defendant gives up certain appeal rights. It is generally enforceable and narrows what can be appealed.
  • “Illegal” sentence (Anderson definition): Not “wrong” or “unfair,” but (1) outside the statutory sentencing range, or (2) unconstitutional.
  • Aggravators and mitigators: Facts a judge considers to increase (aggravate) or decrease (mitigate) the sentence within the lawful range. Errors here are usually discretionary issues, not “illegality.”
  • Abuse of discretion vs. legality: “Abuse of discretion” addresses whether the judge made a reasonable decision within lawful authority; “legality” asks whether the judge had authority to impose that sentence at all.
  • Dismissal without prejudice: The case is closed for now, but the petitioner is not barred from refiling a different petition that properly states an eligible claim.

V. Conclusion

Ortiz cements a practical and doctrinally consequential rule: a defendant who waived sentencing appeals in a plea agreement is not an “eligible defendant” for a PCR 2 belated appeal unless he alleges an Anderson-style “illegal sentence” (outside the statutory range or unconstitutional). Claims that a trial court relied on improper aggravators—classic abuse-of-discretion arguments—do not suffice, even if styled as “unlawfulness.” The decision harmonizes belated-appeal practice with direct-appeal waiver doctrine, resolves lingering appellate conflict, and signals a narrow, carefully policed pathway for waiver-defeating claims going forward.